In people with insulin resistance, obesity, diabetes, dyslipidaemia or metabolic syndrome, several pathways can result in MR overactivation or ‘inappropriate’ MR activation, including changes in MR expression, and modulation of the MR by aldosterone and cortisol.37 The gene discussed is NR3C2; the disease is obesity disorder.